Curative, Adjuvant, Neoadjuvant and Palliative: — What Your Treatment Intent Means

Palliative chemotherapy is treatment — it is treatment with a different goal. The aim is to control the cancer's growth, reduce symptoms, and maintain quality of life rather than to eliminate the cancer entirely. Many people receive palliative chemotherapy for extended periods and feel substantially better while on it. The word palliative describes the intent, not a judgement that treatment is pointless or that the cancer is beyond any response.

It means new information — a scan result, a biopsy finding, or a change in your general health — has led your oncologist to conclude that a different goal is more realistic. This is one of the hardest conversations in cancer care. It is not a failure of treatment or a withdrawal of care. Ask what the change means for your day-to-day life, what treatment continues under the new intent, and what that treatment is expected to achieve. Those are the practical questions that follow.

Neoadjuvant chemotherapy — before surgery — has specific advantages in some situations. A tumour that shrinks before the operation may allow a smaller or less complex procedure. The response to neoadjuvant treatment also tells the oncologist how the cancer behaves at a molecular level, which shapes decisions about treatment after surgery. Whether neoadjuvant or adjuvant sequencing is recommended depends on your cancer type, stage and anatomy — there is no single rule that applies to all cancers.

Ask your oncologist directly at your next appointment. You can say: "Is this chemotherapy aimed at removing the cancer, shrinking it before surgery, or controlling its growth?" That question gets a direct answer in almost every consultation. If you leave still unsure, ask the nurse or treatment coordinator before you leave the centre. Your intent should also appear in your written treatment plan if your centre provides one — ask for a copy if you have not received it.

Yes. Chemotherapy before surgery and chemotherapy after surgery are sometimes both part of the same treatment plan. Whether both are recommended depends on how well the tumour responded to the pre-surgical treatment, what the surgeon found during the operation, and what the evidence supports for your specific cancer type. Your oncologist will explain the full planned sequence at the outset — and revisit it based on how each step goes.

Curative intent means the oncologist believes elimination of detectable cancer is the goal they are working toward — it describes the aim, not a guaranteed outcome. Whether that aim is achieved depends on how the cancer responds to treatment. Regular scans and assessments during treatment tell your team how well it is working. If the response is not what was hoped, the plan may change. Curative intent is the starting point for treatment, not a promise about where it ends.